Answers are grounded in this paper and cite their sources.
Extramammary Paget's disease is a rare intraepithelial malignant condition affecting the apocrine gland-bearing skin. In this case, a genomic alteration, ERBB2 S310F mutation, was discovered. The ERBB2 S310F mutation seems to be a transforming mutation that should be targeted with anti-HER2 drugs. Genomic tests are justified in rare tumors.
No takes yet. Share an insight, caveat, or question.
Vornicova et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: